Opendata, web and dolomites
H2020 projects about "tumor"
The page lists 417 projects related to the topic "tumor".
| # | |||
|---|---|---|---|
| 1 | ULTRAPLACAD | ULTRAsensitive PLAsmonic devices for early CAncer Diagnosis | 2015 |
| 2 | METASPACE | Bioinformatics for spatial metabolomics | 2015 |
| 3 | BeyondSeq | Genomic diagnostics beyond the sequence | 2015 |
| 4 | GLAM | Laser Multiplexed Biosensor | 2015 |
| 5 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 6 | PanCanRisk | Personalized bioinformatics for global cancer susceptibility identification and clinical management | 2015 |
| 7 | GlioVac | Validation of a conceptually new treatment for glioblastoma multiforme with an IP protected small molecule | 2015 |
| 8 | INTRAHETEROSEQ | Molecular characterization of the role of intra-tumor heterogeneity in cancer progression and metastasis | 2015 |
| 9 | Medulloblastoma | Molecularly defined models of human childhood brain tumors | 2015 |
| 10 | SQUALAC | Preclinical development of squalenic acid and gemcitabine squalene nanomedicine | 2015 |
| 11 | EPICUP | Development of a ncRNA DNA Methylation Kit for the Diagnosis of Cancer of Unknown Primary | 2015 |
| 12 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 13 | BALaNCE | BreAking the Link betweeN myo10 and CancEr | 2015 |
| 14 | MAGICBULLET | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | 2015 |
| 15 | RADIATE | Radiation Innovations for Therapy and Education | 2015 |
| 16 | GLYCANC | Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer | 2015 |
| 17 | CancerHetero | Dissection of tumor heterogeneity in vivo | 2015 |
| 18 | CVDTEU | Clinical validation of the DiviTum assay in key European markets | 2014 |
| 19 | BioGuidePCa | Biomarker Guided Prostate Cancer Management | 2014 |
| 20 | FIBERSTAR | FIBER-optic sensors for Smart Thermal Ablation at Radiofrequency | 2016 |
| 21 | Cancer-Drug-Screen | High-throughput drug screening for identifying personalized cancer treatments tailored to the particular mutations of the patient’s tumor | 2015 |
| 22 | BaCTher | Bacteria for Cancer Therapy | 2015 |
| 23 | HspAdhesion | Role of cell membrane associated Hsp70 in cancer cell adhesion and metastasis | 2015 |
| 24 | NIMBLIS | Laser Induced Synthesis of Biocompatible Multifunctional Inorganic Nanoparticles: A Novel Route to Produce Multifunctional Contrast Agents for Early Diagnosis of Breast Cancer | 2016 |
| 25 | WORMTUMORS | Worm power: Can helminths modify the development of colorectal cancer? | 2015 |
| 26 | RejuvenateBone | Enhancing the regeneration of bone defects in elderly: Rejuvenation of bone microenvironment | 2015 |
| 27 | iRhom2 in AD | iRhom2 in neuroinflammation and pathogenesis of Alzheimer’s Disease | 2015 |
| 28 | CARiPSCTcells | Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application | 2015 |
| 29 | MYO-DESMOPLASIA | Modulating the behaviour of cancer myofibroblasts to control tumour desmoplasia | 2015 |
| 30 | MIP4CELL | Molecular Imprinting mediated regulation of cell behavior and related biomedical applications | 2016 |
| 31 | VesSenDrugDeliv | A versatile platform for the design of targeting drug delivery vesicles | 2015 |
| 32 | FiBRO | Fibroblasts in the Biology of Rectal Cancer Progression | 2016 |
| 33 | MatrixMacrophages | Matrix degrading macrophages in cancer growth and invasion | 2015 |
| 34 | BRIDGES | Bioinformatic approaches to identify and detect both disease- and drug-related genomic alterations in breast cancer patients | 2015 |
| 35 | ACM | Cholesterol metabolism as a driver of prostate cancer aggressiveness | 2015 |
| 36 | S-OS | Exosomes as microenvironmental cue for engaging mesenchymal stem cells in osteosarcoma progression | 2016 |
| 37 | ISPADMEC | Integrin specificity in rigidity sensitive proliferation, activation and directional migration of endothelial cells | 2015 |
| 38 | EpiLIVER | Characterization and implications of DNA damage response in liver cancer | 2016 |
| 39 | Lx Micelles | Coordination chemistry in doubly stabilized micelles for the tageted delivery of cytostatic drugs in cancer therapy | 2015 |
| 40 | PROVIST | PROTEASES VISUALIZATION DURING TUMOR PROGRESSION | 2016 |
| 41 | HepatoRiSK | A new tumor suppressor role for RSK2 in hepatocellular carcinoma | 2015 |
| 42 | CELLETEST | Liquid Biopsy blood test in lung cancer diagnosis and monitoring: a next generation noninvasive tumor tracker device | 2015 |
| 43 | Diricore | Exploiting vulnerabilities in protein synthesis for cancer diagnosis and therapy | 2015 |
| 44 | BI-MARK | Clinical validation of the CD32b biomarker on the European market | 2015 |
| 45 | MyNano | Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients | 2015 |
| 46 | FAtoUnFRAGILITY | Fanconi anemia : a disease model to understand causes and consequences of common fragile site instability. | 2015 |
| 47 | VIRION | Viruses, Immune stimulation and RNA Interference in Oncology Network | 2015 |
| 48 | IntraMEMS | Microfluidic platform for intra-operative tumor immunohistochemistry | 2015 |
| 49 | CAPTURE-CTC | A Streptavidin Microarray Platform for Capturing of Circulating Tumor Cells from the Blood of Cancer Patients | 2015 |
| 50 | EpiTALL | Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation | 2015 |
| 51 | PERSYST | Generation and maintenance of long-lived memory T cells in humans | 2015 |
| 52 | IMMUTRAIN | Training Network for the Immunotherapy of Cancer | 2015 |
| 53 | REGiREG | Regulating the immune regulators: targeting adaptive immune control | 2015 |
| 54 | MammaPrint | Improved breast cancer care by innovative diagnostic test MammaPrint | 2015 |
| 55 | BLACANDI | BLACANDI can improve life quality and cut cost of diagnosing and managing bladder cancer in half | 2015 |
| 56 | platinDx | A test for predicting the efficacy of common platinum drugs enabling personalized chemotherapy for bladder cancer patients. | 2015 |
| 57 | DERMAE | Clinical research for the validation of a non-invasive medical imaging device for dermatological diagnoses | 2015 |
| 58 | COMBIOSCOPY | Computational Biophotonics for Endoscopic Cancer Diagnosis and Therapy | 2015 |
| 59 | PROTEOMICAN | Discovery of breast cancer aggressiveness markers using topo-proteomics mapping | 2015 |
| 60 | MetCAF | Uncovering the Role of Cancer Associated Fibroblasts in Facilitating Breast Cancer Metastasis | 2015 |
| 61 | PROMETHEUS | Novel Cells for Organ Repair | 2015 |
| 62 | LEGO | Multimodal glycoconjugates: a molecular Lego approach for antitumoral immunotherapy | 2015 |
| 63 | TARLOOP | R-loops as a major modulator of transcription-associated recombination and chromatin dynamics | 2015 |
| 64 | PHII | PTX3 in Humoral Innate Immunity | 2015 |
| 65 | AUROMYC | N-Myc and Aurora A: From Protein Stability to Chromosome TopologyN-Myc and Aurora A: From Protein Stability to Chromosome TopologyMyc and Aurora A: From Protein Stability to Chromosome Topology | 2015 |
| 66 | DENOVOSTEM | DE NOVO GENERATION OF SOMATIC STEM CELLS: REGULATION AND MECHANISMS OF CELL PLASTICITY | 2015 |
| 67 | ZAUBERKUGEL | Fulfilling Paul Ehrlich’s Dream: therapeutics with activity on demand | 2015 |
| 68 | GLIOMARK | Validation of blood-brain-barrier permeability as a glioma biomarker by means of the radiotracer 99mTc-tetrofosmin and single-photon emission computer tomography | 2015 |
| 69 | p38Cure | New breast cancer therapies based on available p38 MAPK inhibitors | 2015 |
| 70 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 71 | IL7sigNETure | IL-7/IL-7R signaling networks in health and malignancy | 2015 |
| 72 | Cancer-Recurrence | Tumor cell death supports recurrence of cancer | 2015 |
| 73 | EPIGEN | EPIGEN: A New Predictive Response Test for Non Small Cells Lung Cancer Treatment | 2015 |
| 74 | IXSI3D | Translating Hybrid Imaging for Interventions: Intra-operative Guidance and Evaluation using 2D and 3D Interventional X-ray Scintigraphy Imaging | 2015 |
| 75 | Colodetect | Development of a novel blood-based diagnostic test for colorectal cancer | 2015 |
| 76 | MASCP | Mechanisms of alternative pre-mRNA splicing regulation in cancer and pluripotent cells | 2015 |
| 77 | uPET | Molecular imaging and targeted therapy of the aggressive phenotype: development of uPAR theranostics for cancer patients | 2015 |
| 78 | SLACC | Supplying lung adenocarcinoma cell lines to the cancer research community. | 2015 |
| 79 | AcTafactors | AcTafactors: Tumor Necrosis Factor-based immuno-cytokines with superior therapeutic indexes | 2015 |
| 80 | ARRAY SEQ | Array-tagged single cell gene expression by parallel linear RNA amplification and sequencing | 2015 |
| 81 | RCC-TEST | A breakthrough in Renal Cell Carcinoma: Personalized RCC-Test | 2016 |
| 82 | ClearPEMplus | Enhanced Silicon Photomultiplier-based detectors for high-resolution Positron Emission Mammography. | 2015 |
| 83 | PanCaT | Next-generation in vivo models for improved pancreatic cancer therapies | 2016 |
| 84 | Angiolnc | Endothelial long non-coding RNAs | 2016 |
| 85 | Organoid | Dissecting microbiome and immune interactions in human intestinal (cancer) organoids | 2015 |
| 86 | CONQUEST | Companion Nanodiagnostics for Quantifying EPR and Stratifying Patients to Targeted Nanotherapies | 2016 |
| 87 | DESIREE | Decision Support and Information Management System for Breast Cancer | 2016 |
| 88 | VACTRAIN | TWINNING ON DNA-BASED CANCER VACCINES | 2016 |
| 89 | PolyDrug Discovery | Discovery of anticancer polymeric drugs that mimic the action of TRAIL | 2016 |
| 90 | BD2Decide | Big Data and models for personalized Head and Neck Cancer Decision support | 2016 |
| 91 | MAINTRAC-Auto | MAINTRAC-Auto: Automatization and validation of a liquid biopsy assay “Maintrac-AUTO CTC-analyser” for predictive real time monitoring and success control of solid tumor cancer therapy | 2016 |
| 92 | epiGERMetics | Landscape of epigenetic control in early and late germ line development | 2016 |
| 93 | OptiQ-CanDo | Hybrid Optical Interferometry for Quantitative Cancer Cell Diagnosis | 2016 |
| 94 | ICARO | Colloidal Inorganic Nanostructures for Radiotherapy and Chemotherapy | 2016 |
| 95 | HyGlio | Theranostic Injectable Hydrogel for Glioblastoma | 2016 |
| 96 | HOLDING-HANDS | Holding hands: cell-cell junctions in breast cancer metastasis and resistance to therapy | 2016 |
| 97 | BARCODE DIAGNOSTICS | Next-Generation Personalized Diagnostic Nanotechnologies for Predicting Response to Cancer Medicine | 2016 |
| 98 | TissueMaps | Integrating spatial and genetic information via automated image analysis and interactive visualization of tissue data | 2016 |
| 99 | MCNANO | “Multi-component nanoparticles as bimodal contrast agents for MRI and optical detection of tumors and for targeted photodynamic therapy” | 2016 |
| 100 | SLIM | Synthetic Lethal Interactions with nucleophosMin 1 | 2016 |
| 101 | PDA_TGFb | TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis | 2017 |
| 102 | MIRNANO | Multifunctional miRNA-targeting nanodevices for pluripotent cancer theranostics | 2017 |
| 103 | INTEGRISTEM | Functions of Integrins in Mammary Stem Cell Activity and Tumorigenesis | 2016 |
| 104 | SMART-LANLIGHT | New Scanning nearfield Microscopy method bAsed on Radio-frequency Trap and LANthanide nanoprobe for LIGHT matter interaction. | 2016 |
| 105 | MolecularEVOLUTION | Molecular Evolution of the Primary Structure of Single Chain Polymer Nanoparticles via Dynamic Covalent Chemistry | 2016 |
| 106 | Exosomes | Regulated secretion and role of urinary nanovesicles | 2017 |
| 107 | PERICYTEStroma | Pericyte-derived tumor stroma – a target for cancer therapy | 2016 |
| 108 | ENVERESP | Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity | 2016 |
| 109 | RAC | Defining the Role of Antioxidants on Cancer progression and metastasis | 2016 |
| 110 | EC GNG metabolism | Endothelial Gluconeogenesis: a novel target for tumor anti-angiogenesis? | 2017 |
| 111 | OPTIM | Optimized drug combinations for effective cancer treatment: a personalised approach. | 2016 |
| 112 | SYNVIA | Synthetic viability of homologous recombination-deficient cancers | 2016 |
| 113 | DLL4-LVN | Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma | 2017 |
| 114 | 2MoveMate4Melanoma | A treatment for BRAF inhibitor resistant melanoma | 2016 |
| 115 | HEAL-BY-MIRNA | microRNA replacement therapy for mature B cell neoplasias | 2016 |
| 116 | CLONCELLBREAST | CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT | 2017 |
| 117 | MYCLASS | Towards prevention, early diagnosis, and noninvasive treatment of uterine leiomyomas through molecular classification | 2016 |
| 118 | Lumiblast | A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours | 2016 |
| 119 | PeptiCrad | Personalized oncolytic vaccines for cancer immunotherapy | 2016 |
| 120 | TiDrugArchitectures | Highly Competent and Safe Titanium(IV) Therapeutic Frameworks that are Cancer Targeted based on Complex 1, 2, and 3D Chemical Architectures | 2016 |
| 121 | Tamed Cancer | Personalized Cancer Therapy by Model-based Optimal Robust Control Algorithm | 2016 |
| 122 | REPLICONSTRAINTS | Dissecting the constraints that define the eukaryotic DNA replication program | 2016 |
| 123 | Immune-senescence | Dual targeting of senescence and tumor immunity for cancer therapy | 2016 |
| 124 | STEM-BCPC | Signal Transduction and Epigenetic Mechanisms of Breast Cell Plasticity and Cancer | 2016 |
| 125 | PCFENCM | Pan-cancer functional evaluation of non-coding DNA mutations | 2017 |
| 126 | TENSION | Targeting replication stress recovery pathways in oncology | 2016 |
| 127 | PLEIO-RANK | Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity | 2016 |
| 128 | CDK6-DrugOpp | CDK6 in transcription - turning a foe in a friend | 2016 |
| 129 | ZMOD | Blood Vessel Development and Homeostasis: Identification and Functional Analysis of Genetic Modifiers | 2016 |
| 130 | TNT-TUMORS | Therapeutic approaches to enhance innate immunity against Tumors | 2016 |
| 131 | AngioResist | Coordinated Development of Inhibitors and Biomarkers for Resistance to Antiangiogenics in Cancer - AngioResist | 2016 |
| 132 | PolyP-FXII in cancer | The polyphosphate/factor-XII pathway in cancer-driven thrombosis and tumor growth | 2017 |
| 133 | CoCa | Collagen in Cancer: from the regulatory fibril forming function of collagen V in development to its implication in tumor progression | 2016 |
| 134 | TRANSREAD | Restoration of tumor suppressor function by induction of translational read-through of premature termination codons - a strategy for improved cancer therapy | 2016 |
| 135 | BRCANCER | A novel approach for modeling development of breast cancer | 2016 |
| 136 | TRANSMIT | TRANSlating the role of Mitochondria in Tumorigenesis | 2017 |
| 137 | EN_ACTI2NG | European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry | 2017 |
| 138 | EPIPHARM | Development of a ncRNA DNA Methylation Kit for Treatment Guidance in Cancer of Unknown Primary | 2017 |
| 139 | EMbRACe | Effective Multidrug Cocktails for Cancer | 2016 |
| 140 | PAMMOTH | Photoacoustic/Ultrasound Mammoscopy for evaluating screening-detected abnormalities in the breast | 2017 |
| 141 | HypoSens | Nano-confined photonic system for detection of breast cancer spread to the lymph nodes | 2016 |
| 142 | THERACAN | Novel therapeutic strategies to treat pancreatic and lung cancer | 2017 |
| 143 | TILC | Targeting Innate Lymphoid Cells | 2017 |
| 144 | DiVineGenoMe | Decoding cell-to-cell variation in genome integrity maintenance | 2017 |
| 145 | MECHANO-FLUO | Mechanofluorochromism: from molecular engineering to the elaboration of smart materials | 2017 |
| 146 | iGBMavatars | Glioblastoma Subtype Avatar models for Target Discovery and Biology | 2017 |
| 147 | SweetAim | Selective glycoimmuno-targeting for cancer therapy | 2016 |
| 148 | SLaMM | Magnetic Solid Lipid Nanoparticles as a Multifunctional Platform against Glioblastoma Multiforme | 2017 |
| 149 | EVOLVE | Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy | 2017 |
| 150 | ONCOCHECK | A simple blood test for prognosis and monitoring of patients undergoing cancer therapy. | 2017 |
| 151 | MetResistance | The role of tumour microenvironment in metastatic hormone-refractory prostate cancer | 2017 |
| 152 | VIVAVE | Viral Vaccine Vectors in Personalized Medicine | 2017 |
| 153 | THUNDER | Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir | 2017 |
| 154 | PREDICT | PREcision medicine Drug combination testing In neuroblastoma organoids to guide Clinical Trials | 2017 |
| 155 | ONCOmetENHANCERS | Elucidating the Role of Enhancer Methylation Variation in Cancer and Developing Enhancer-based Markers and Targets for Precision Medicine | 2017 |
| 156 | RepliStressTiming | Impact of replicative stress on DNA replication timing control | 2017 |
| 157 | MSIOAM | Multifocal structured illumination optoacoustic microscopy | 2018 |
| 158 | CRISTONE | Targeting CRISPR-based HDAC inhibitors to histones: a new tool for assessing mechanisms of class I HDAC inhibitors and developing chemical probes. | 2017 |
| 159 | ColoFILM | Multifunctional polymeric film-based drug delivery system for oral anti-TNF-alpha-based inflammatory bowel disease therapy | 2017 |
| 160 | EpiMethFly | Study of the role of m6A RNA methylation in the nervous system of Drosophila melanogaster: an in-vivo model to dissect the impact of epitranscriptome reprogramming in physiology and cancer | 2017 |
| 161 | DrugSearchTool | Innovative FRET-based toolkit for screening of drugs to fight miRNA-related diseases and its use in the development of cancer treatment with miRNA-96 as a therapeutic target | 2018 |
| 162 | Monomark | A comparative clinical study of a stool-based versus a blood-based screening test for earlydetection of CRC | 2017 |
| 163 | DREMATURE | DNA repair mechanisms and therapy resistance of BRCA2-deficient cancers | 2018 |
| 164 | NANOCANCER | Getting new insights into the radio-sensitization effects of nanoparticles in photon and charged particle therapy | 2017 |
| 165 | MSCFate | Fate of mammary stem cells during tumorigenesis and clinical implications | 2017 |
| 166 | APACHE | Atmospheric Pressure plAsma meets biomaterials for bone Cancer HEaling | 2017 |
| 167 | MiRCHOL | Mechanistic and therapeutic implications of microRNA deregulation for drug resistance in bile duct cancer | 2017 |
| 168 | iChip | Intestine-on-a-chip for investigating microbioal-epithelail interaction | 2018 |
| 169 | EwiSarc | A novel in vivo platform to study and target undruggable Ewing onco-chimera. | 2017 |
| 170 | Immunometabolomics | CD8+ T cell metabolism in anti-tumor response | 2017 |
| 171 | AcTaferon | Revitalizing the clinical potential of type I IFNs in fighting influenza A virus infections with AcTaferon. | 2017 |
| 172 | ONCOPHAGY | Novel Atg4B-inhibitors and dual [Atg4B-carbonic anhydrase]inhibitors for interfering with cytoprotective mechanisms of cancercells in the acidic tumor micro-environment. | 2017 |
| 173 | Prolifimeter | Growth detection and quantification (GDQ) | 2017 |
| 174 | DUALITY | An Integrated Computational and Experimental Approach to Rapid Synthesis of Highly Selective Dual-Targeted HDAC/CK2, MMP2/CK2 Inhibitors | 2018 |
| 175 | CINK | Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers | 2018 |
| 176 | METCLL | Discovery and validation of ‘epidrivers’ of cancer evolution and resistance to therapy | 2018 |
| 177 | RoNDBioCan | NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway | 2018 |
| 178 | IC_IL_EC_2017 | Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers | 2018 |
| 179 | THAT IS HUNT | Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors | 2018 |
| 180 | PlateletLiquidBiopsy | Exploring the cellular heterogeneity underlying 'tumor-educated' platelets | 2017 |
| 181 | Hepatocarcinoma IVM | Spatiotemporal dynamics of CD8+ T cell responses to hepatocellular carcinoma | 2017 |
| 182 | ONCOGENEVOL | The evolutionary history of oncogenic and non-oncogenic papillomaviruses | 2017 |
| 183 | TANTUMorNEUVACCINE | Neutrophil subtypes: distinct cellular targets for therapeutic intervention | 2017 |
| 184 | ONCOSYSTEMS | Phenotypic characterization of Liver-derived exosomes populations associated with liver metastasis in pancreatic cancers | 2017 |
| 185 | protonCBCT | Proton CT reconstruction with a Cone Beam CT prior | 2017 |
| 186 | QUSMI | Translating quantum sensing into cost-effective molecular imaging | 2017 |
| 187 | CTCapture_2.0 | Advanced platform for profiling of therapeutic targets and functional analysis of circulating tumour cells in cancer patients | 2017 |
| 188 | INTUMORX | Elucidation of intratumoral heterogeneity in Kras-driven cancers | 2017 |
| 189 | TryptoBoost | Boosting tryptophan fluorescence with optical nanoantennas to watch label-free protein dynamics with single molecule resolution at high concentration | 2017 |
| 190 | TIGITtherapy | TIGIT therapy for cancer treatment | 2017 |
| 191 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2017 |
| 192 | ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | 2017 |
| 193 | FATE | Functional Biology of Hepatic CD8+ T cells | 2017 |
| 194 | CATCH-U-DNA | Capturing non-Amplified Tumor Circulating DNA with Ultrasound Hydrodynamics | 2017 |
| 195 | INTACt | ImmuNogenomics TArgeting Cancer | 2017 |
| 196 | DynaCOMP | Assessing compounds targeting DNA replication licensing complexes as anti-tumor agents | 2017 |
| 197 | MammoWave | The first ultra-high sensitive breast imaging device based on non-ionizing safe microwave | 2017 |
| 198 | STOPCa | The cryptic path of tumor-microenvironment interactions in prostate cancer | 2017 |
| 199 | u-PBeam | Microdosimetry study of a new radiation therapy method based on proton minibeams | 2017 |
| 200 | V-EPC | Inherited disfunctions of brain microcirculation | 2017 |
| 201 | ZEBRAONCOFISH | Zebrafish avatar as a real-time in vivo platform for personalized cancer therapeutics | 2017 |
| 202 | AMPHORA | ACOUSTIC MARKERS FOR ENHANCED REMOTE SENSING OF RADIATION DOSES | 2017 |
| 203 | META-CAN | Targeting the metabolism-immune system connections in Cancer | 2017 |
| 204 | StroMaP | Stromal stress networks underlying phenotypic plasticity and tumor fitness | 2017 |
| 205 | ARMOR-T | Armoring multifunctional T cells for cancer therapy | 2018 |
| 206 | ImPRESS | Imaging Perfusion Restrictions from Extracellular Solid Stress | 2018 |
| 207 | MICRONEX | Microbioreactor platforms as in vivo-like systems to probe the role of Neuroblastoma-derived Exosomes in cancer dissemination | 2017 |
| 208 | TECNEC | Preclinical concept validation of tumor endothelial cell metabolism for novel anti-angiogenic therapy | 2017 |
| 209 | NANONC | Nanomaterials in Oncology: Exploiting the Intrinsic Cancer-Specific Toxicity of Nanoparticles. | 2018 |
| 210 | X-TAM | Dissecting Cross-Regulatory Interplays in Tumor-Associated Macrophages | 2018 |
| 211 | NEOSETAC | New Selenium-based Targeted Nanocapsules to treat Breast Cancer | 2018 |
| 212 | JetCell | Microfluidic bubble JET flow CELL sorter for cell therapy | 2018 |
| 213 | SENSIT | Sensitivity of human tumors to T cell attack | 2017 |
| 214 | NANOCARGO | Photo/magnetic stimulated nanocargos for superior cancer treatments | 2018 |
| 215 | CLINGLIO | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. | 2017 |
| 216 | LIMA | Liquid biopsies and Imaging for improved cancer care | 2018 |
| 217 | ELIMINATE | Development of strategies to eliminate cancer cells from the bone marrow | 2018 |
| 218 | CANCER-DC | Dissecting Regulatory Networks That Mediate Dendritic Cell Suppression | 2018 |
| 219 | GlycoEdit | New Chemical Tools for Precision Glycotherapy | 2017 |
| 220 | CombaTCancer | Rational combination therapies for metastatic cancer | 2018 |
| 221 | DualRP | Exploring cell interactions in the tumor microenvironment with dual ribosome profiling | 2018 |
| 222 | REMIX | Regenerative Medicine Innovation Crossing - Research and Innovation Staff Exchange inRegenerative Medicine | 2017 |
| 223 | OncoSeq | OncoSeq: an innovative single-cell system for immunomonitoring | 2017 |
| 224 | OneRNA4Bladder | Non invasive Cell Based Liquid Biopsy Platform for Bladder Cancer | 2017 |
| 225 | CTC-MAL | Isolation of rare circulating tumor cells | 2018 |
| 226 | MEL-Interactions | An integrative approach for the exploration of melanoma genetic and immunological interactions | 2018 |
| 227 | MicroCaT | Micro-tumor Guided Cancer Therapy Selection MicroCaT | 2018 |
| 228 | ImmunoFit | Harnessing tumor metabolism to overcome immunosupression | 2018 |
| 229 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
| 230 | Re-MAPMATH | Re-Mapping the Numerical Brain. | 2018 |
| 231 | IMMUNOMARK | Omics integration for precision cancer immunotherapy | 2018 |
| 232 | INSPIRE | Instrument Shape Sensing for Minimally Invasive Interventions | 2018 |
| 233 | LASER OPTIMAL | Laser Ablation: SElectivity and monitoRing for OPTImal tuMor removAL | 2018 |
| 234 | TCELLTIGIT | Structural characterization of immune signaling protein TIGIT using x-ray crystallography and cryo-electron microscopy | 2019 |
| 235 | SenPET | Innovative cancer management: First in human senescence imaging | 2018 |
| 236 | UTILIUM | Unraveling The Immune Landscape In Uveal Melanoma | 2018 |
| 237 | TheraSonix | Ultrasonic Imaging and Drug Propulsion Into Tumors Using Genetically Encoded Gas Nanostructures | 2018 |
| 238 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 239 | Tick ThaNK | Tick-borne encephalitis Targeted by Human Active NK cells | 2019 |
| 240 | ONCOTHERANOSTICS | Advanced Theranostic Nanomedicines for Oncology. Development of new combinatorial therapies for primary and metastatic Breast Cancer. | 2019 |
| 241 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
| 242 | MTOAC | Multi-compartmental Tumor-on-a-Chip | 2018 |
| 243 | InTheMLLrBALL | Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia | 2018 |
| 244 | HYPTEMPCELL | Local hyperthermia cancer treatment studies using a new temperature-imaging-hyperthermia-microscopy instrument | 2018 |
| 245 | MDCRC | Metabolic Dynamics in Colorectal Cancer | 2018 |
| 246 | PNECtumor | Mechanisms regulating pulmonary neuroendocrine cell (PNEC) growth and tumorigenesis | 2019 |
| 247 | ProCenDecl | Synthesis and validation of chemical Probes for Centrosome Declustering: development of potent and selective anti-cancer agents. | 2019 |
| 248 | RE-IMMUNE | Intelligent Nano-encapsuled siRNA for Restoring Immune Cell Response to Cancer | 2019 |
| 249 | VulneraBAP1 | Mechanism and vulnerability of BAP1 loss in tumor metastasis | 2018 |
| 250 | M-Lysosomes | Identification of a novel function of lysosomes in mitosis for cancer therapy | 2019 |
| 251 | FUCTURE | Fucosylated Clusterin: a novel mechanism of tumor escape from immune response | 2018 |
| 252 | PROCHIP | Chromatin organization PROfiling with high-throughput super-resolution microscopy on a CHIP | 2018 |
| 253 | SEQURE | Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer | 2018 |
| 254 | TRANSREG | Dissecting the role of Translational Regulation in Tumorigenesis | 2018 |
| 255 | MATURE-NK | MAnufacturing of TUmour-REactive Natural Killer cells | 2018 |
| 256 | POLICE | The PIDDosome in Centrosome and Ploidy-Surveillance | 2018 |
| 257 | RadioClick | A versatile ultrafast Click platform for antibody based radio diagnostics | 2018 |
| 258 | AUTO NERVE | Tracers for targeting nerves in the autonomic nervous system | 2018 |
| 259 | pBioStrat-for-PDA | Use of PAP as a biomarker and stratifier of pancreatic cancer to improve patient management | 2018 |
| 260 | mTORmorS | Role of mTOR signaling dysregulation in the tumor suppressor networks in hepatocellular carcinoma | 2019 |
| 261 | EDIT | Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma. | 2018 |
| 262 | TALVIN | Inhibiting mechanotransduction for the treatment of pancreatic cancer | 2018 |
| 263 | B2B | Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity. | 2018 |
| 264 | VES4US | Extracellular vesicles from a natural source for tailor-made nanomaterials | 2018 |
| 265 | SENSITIVE | Early Detection of cancer onset based on sensing field cancerization at the organ level | 2018 |
| 266 | LIPOMET | Dietary Influences on Metastasis: How, When, and Why | 2018 |
| 267 | SelectiveTGFb-inhib | Pro-tumorigenic effects of TGFb - elucidation of mechanisms and development of selective inhibitors | 2018 |
| 268 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 269 | RV001 | RV001: An anti-metastatic cancer vaccine | 2018 |
| 270 | HyperCollar3D | Improving the Treatment of Head and Neck Cancer without Additional Side Effects | 2018 |
| 271 | MOOD | Feasibility Study for the introduction into pre-clinical study domain of the first-of-a-kind Multi Organ On Device (MOOD) technology | 2018 |
| 272 | HistologTM Scanner | Intra-operative microscope for tumor margin assessment | 2018 |
| 273 | ONCOscanner | ONCOscanner – oncological probe for intra-operative identification of cancerous tissues during surgical treatment for breast cancer | 2018 |
| 274 | UNLEASHAD | Unleashing the curative potential of cancer immunotherapy | 2018 |
| 275 | PaSION | A longitudinal assessment of treatment experience, symptoms and potential associations with biomarkers in cancer patients undergoing immune checkpoint inhibitor therapy | 2018 |
| 276 | ONCOSMART | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2018 |
| 277 | STARNEL | supracellular contractility of myofibroblasts in gut homeostasis and cancer invasion | 2018 |
| 278 | REACT | REsponsive theranostic nanosystems for Advanced Cancer Treatment | 2019 |
| 279 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
| 280 | I-DireCT | Immune DIREcted and Cancer-selective immunoTherapy | 2019 |
| 281 | RxmiRcanceR | Tumor suppressive microRNAs for cancer therapy | 2018 |
| 282 | STIMUNO | Searching for novel strategies improving cancer immunotherapy | 2019 |
| 283 | TREAT-PD | Patient-specific treatment for Parkinson's disease using reprogrammed skin cells | 2018 |
| 284 | MitoGuide | Integration and adaptation of impaired mitochondrial fitness in orchestrating T cell dysfunction in the tumor microenvironment | 2019 |
| 285 | NextGen IO | Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology | 2019 |
| 286 | INFORE | Interactive Extreme-Scale Analytics and Forecasting | 2019 |
| 287 | FIBROHALT | Advancing a novel peptide-based therapeutic for pancreatic cancer | 2018 |
| 288 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 289 | GLIOVACC | Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | 2018 |
| 290 | LUMAX | Innovative Laser and Fiber System for Non-Toxic, Efficient and Cost-Effective Treatment of Cancer | 2018 |
| 291 | CancerQR | Next generation cancer therapies targeting cancer networks | 2019 |
| 292 | ESCALON | European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development | 2019 |
| 293 | SELNET | Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network | 2019 |
| 294 | TIL-FIT | Increasing the fitness of tumor-infiltrating T cells for cellular immunotherapy | 2019 |
| 295 | METANICHE | Regulation of bone metastases by age-associated angiocrine signals | 2019 |
| 296 | iNANOVAC4CANCER | BIOHYBRID AND BIODEGRADABLE NANOVACCINES FOR CANCER IMMUNOTHERAPY | 2019 |
| 297 | BBBhybrid | Advanced in vitro physiological models: Towards real-scale, biomimetic and biohybrid barriers-on-a-chip | 2019 |
| 298 | NanoBRIGHT | BRInGing nano-pHoTonics into the brain | 2019 |
| 299 | DCRIDDLE | A novel physiological role for IRE1 and RIDD..., maintaining the balance between tolerance and immunity? | 2019 |
| 300 | PRinTERs | Post-transcriptional regulation of effector function in T cells by RNA binding proteins | 2019 |
| 301 | ViroPedTher | Oncolytic viruses for the treatment of pediatric brain tumors: An integrated clinical and lab approach | 2019 |
| 302 | ImmunoBioSynth | Synergistic engineering of anti-tumor immunity by synthetic biomaterials | 2019 |
| 303 | CancerFingerPrints | Identification of nano-mechanical fingerprints as a biomarker for cancer treatment prognosis | 2019 |
| 304 | Olfactomics Surgery | BRINGING SURGERY TO THE 21ST CENTURY: REAL-TIME TISSUE ANALYSIS DURING CANCER SURGERY. Improving Patient Safety, Quality and Cost-Effectiveness | 2019 |
| 305 | SECRETE-HF | SECRETED FACTORS IN CARDIAC REMODELING PROVOKE TUMORIGENESIS AND END ORGAN DAMAGE IN HEART FAILURE | 2019 |
| 306 | Cluster-Buster | Development of small molecule inhibitors of circulating tumor cell clusters | 2019 |
| 307 | IntratumoralNiche | Defining heterocellular signalling within the intratumoral stem cell niche of colorectal cancer | 2019 |
| 308 | CRC-MTOs | Colorectal Cancer Mouse Tumor Organoids as Pre-clinical Models for Therapeutical Testing | 2018 |
| 309 | VESSEL CO-COPTION | Vessel co-option and radioresistance in glioblastoma | 2019 |
| 310 | Visual Proteomics | Biomarker discovery by AI-guided, image based single-cell isolation proteomics | 2019 |
| 311 | IMaP | Imaging tumor vessels as a marker for p53 mutation status in cancer | 2020 |
| 312 | Biosensor Design | Engineering Chemotactic Biosensors for a Diverse Spectrum of Metastatic Markers | 2020 |
| 313 | REAP | Repair of DNA lesions induced by platinum drugs | 2019 |
| 314 | CApaCITy | CAncer Stem Cell Imunoreceptors as potential Targets for skin Squamous cell carcinoma | 2019 |
| 315 | GLIOHAB | Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation | 2019 |
| 316 | EOBRECA | Differential Roles of Estrogens in Obesity-mediated ER+ Breast Cancer Development | 2019 |
| 317 | EVOMET | The rise and fall of metastatic clones under immune attack | 2019 |
| 318 | PCinBC | Plasma cell heterogeneity and dynamics in patient tumors | 2019 |
| 319 | SyLeNCe | Synapses between Leukaemia and its Neighbouring Cells | 2020 |
| 320 | ImmunoMECH | High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment | 2019 |
| 321 | THERAPROBES | Biodegradable fluorescent nanoprobes for early detection of (pre)malignant lesions of the gastrointestinal tract | 2019 |
| 322 | PB_dormancy | Insertional mutagenesis to identify molecular mechanisms of breast cancer dormancy and metastasis | 2020 |
| 323 | Exh-Res-CART | Exhaustion-resistant CAR-T cells for the treatment of solid tumours | 2019 |
| 324 | IEOCCD | THE IMPACT OF THE ENVIRONMENT AND ONCOGENESIS ON CANCER CELL DIVISIONS | 2019 |
| 325 | PanILC | Deciphering type 2 innate lymphoid cell/epithelial progenitor cell crosstalk in pancreas regeneration and neoplasia | 2019 |
| 326 | MGLycan | Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer | 2019 |
| 327 | META2 | METAbolism of bone METAstasis (META2): Metabolic interactions between disseminated breast cancer cells and osteoblast lineage cells drive bone metastases formation | 2019 |
| 328 | PredAlgoBC | Machine learning prediction for breast cancer therapy | 2019 |
| 329 | ICE-METs | Interstitium-on-a-chip to explore its role in cancer metastasis | 2019 |
| 330 | SingCelCD | Single Cell approaches for the study of oncogenic processes during coeliac disease. | 2019 |
| 331 | MINT | Multifunctional Immunocompatible NanoTheranostics to modulate tumor microenvironment and improve treatment monitoring: A double blow to pancreatic cancer | 2019 |
| 332 | Tumor microbiome | The tumor microbial communities: Characterization, effects and translational opportunities | 2019 |
| 333 | BRAIN-MATCH | Matching CNS Lineage Maps with Molecular Brain Tumor Portraits for Translational Exploitation | 2019 |
| 334 | IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts | 2019 |
| 335 | Biochip-images | A Breast Cancer Biomarker Point of CarePOCDiagnostic Platform Integrating Dual-Functionalized Nanoparticle for Magnetic Gradient Ranking and Electrochemical Sensing | 2019 |
| 336 | OncoViroMRI | Brain Cancer Therapy Monitoring using a Novel Quantitative and Rapid Magnetic Resonance Imaging-based Method | 2019 |
| 337 | FUNTRICAN | Functional analysis of thyroid hormone nuclear receptors TRs in human Intestinal Cancer stem cells | 2019 |
| 338 | SUPERBRAIN | Magneto-Plasmonic, Raman active Nanocapsules for Superior Pediatric Brain Cancer Therapy | 2020 |
| 339 | MIMIC | Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy | 2020 |
| 340 | BITFORM | Multiplexed biosensing and tissue-on-a-chip integrated platform for breast cancer biomarkers monitoring | 2019 |
| 341 | Recruit | Origin and Function of Tumor-Associated Macrophages and Mesenchymal Stromal Cells in GBM Subtypes | 2019 |
| 342 | CB-103 | First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers | 2019 |
| 343 | Hyalcis | Hyaluronic-Cisplatin Film for Implant in Malignant Mesothelioma Recurrence | 2019 |
| 344 | HighResCells | A synergistic approach toward understanding receptor signaling in the cell at very high resolution | 2019 |
| 345 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 346 | EPICAN | Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer | 2020 |
| 347 | ONCOTECT | Early detection of tumor DNA in liquid biopsies as a biomarker of cancer recurrence | 2019 |
| 348 | ONCO-BOOST | Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies | 2019 |
| 349 | SPLITVAC | Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines | 2019 |
| 350 | 3DBrainStrom | Brain metastases: Deciphering tumor-stroma interactions in three dimensions for the rational design of nanomedicines | 2019 |
| 351 | CTI | A novel, efficient and minimally invasive medical procedure to treat anastomotic leakage during colorectal cancer surgery. | 2019 |
| 352 | Genetic Vaccine | Study the therapeutic and preventive potential of targeting oncogenic mutations with CRISPR-Cas9 technology | 2019 |
| 353 | UNPACK PD-L1 | Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells | 2020 |
| 354 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2019 |
| 355 | NEXIM | A Next-generation targeted immuno-oncology therapy | 2019 |
| 356 | T-NHL SUPRESSORS | Tumor suppressor pathways counteracting oncogenic immune receptor signaling in T-Cell Lymphoma | 2019 |
| 357 | VACCIBIOME | Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy | 2019 |
| 358 | Anti-L1CAM | Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients | 2019 |
| 359 | TOPAS | Exploiting the Tumor Proteome Activity Status for Future Cancer Therapies | 2019 |
| 360 | TAcTIC | TArgeTed molecular Imaging and surgery for gastro-intestinal Cancer | 2019 |
| 361 | INJURMET | Impact of tissue injury induced by diagnostic biopsies and surgery on cancer metastasis | 2019 |
| 362 | TK-NEO | Personalized Cancer Immunotherapy through DNA-EP vaccines | 2019 |
| 363 | FRAME | FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf | 2019 |
| 364 | SECRET | Exploitation of the SECRETory pathway for cancer therapy to address European research | 2019 |
| 365 | THERADNET | International NETwork for training and innovations in THErapeutic RADiation | 2019 |
| 366 | HEPCAN | A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 |
| 367 | 3DCanPredict | Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy | 2019 |
| 368 | SLAM-Dx | Diagnostic drug response-profiling using SLAMseq | 2019 |
| 369 | Magicbullet Reloaded | Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy | 2019 |
| 370 | RV001 | RV001: An anti-metastatic cancer vaccine | 2019 |
| 371 | ABODYFORCE | High Throughput Microfluidic Cell and Nanoparticle Handling by Molecular and Thermal Gradient Acoustic Focusing | 2019 |
| 372 | EPICAMENTE | At the epigenetics-cancer metabolism interface | 2019 |
| 373 | TroyCAN | Redefining the esophageal stem cell niche – towards targeting of squamous cell carcinoma | 2020 |
| 374 | GelGeneCircuit | Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic circuits. | 2020 |
| 375 | PROT-RESIST | Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer | 2019 |
| 376 | TrojanDC | TrojanDC | 2019 |
| 377 | ONco-Energetics_OFF | Dissection of Bioenergetic Plasticity of Tumors | 2020 |
| 378 | RESCUER | RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER. | 2020 |
| 379 | RhabdoEvo | Deciphering the cellular origin and evolution of malignant rhabdoid tumors | 2019 |
| 380 | Synthetic T-rEX | A synthetic biology approach for T cell exhaustion | 2020 |
| 381 | TOPOCELL | A cell separation microfabricated platform for cell migration and invasion assays | 2020 |
| 382 | STI-001 | Turn Cancer Immunotherapy Effective in Most Patients | 2019 |
| 383 | Lottare GBM | LOcalized Targeted Therapy to Avoid REcurrent GlioBlastoma Multiforme | 2019 |
| 384 | READY | Getting ready to treat human patients with nanobody-targeted photodynamic therapy | 2020 |
| 385 | MATCH | Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research | 2020 |
| 386 | Meta-Targeting | Macro-Nanomedicine to Treat Metastatic Cancer | 2020 |
| 387 | HyperCube | HyperCube: Gram scale production of ferrite nanocubes and thermo-responsive polymer coated nanocubes for medical applications and further exploitation in other hyperthermia fields | 2020 |
| 388 | SILENT | Silent mutations in cancer | 2020 |
| 389 | TrojanDC | Harnessing dendritic cell reprogramming for cancer immunotherapy | 2020 |
| 390 | NIMBUS4CIP | Effective management of pregnant cancer patients through a cloud-based integrative and highly specialized advisory board platform | 2020 |
| 391 | Droplet Microarray | Miniaturized System for Screening of Primary Cells based on Droplet Microarray | 2020 |
| 392 | TACT | Targeted Anti-Cancer Therapies | 2020 |
| 393 | METABOLIGHT | Optical imaging platform to unravel metabolic reprogramming of cancer: a path for improved treatments | 2020 |
| 394 | Ru4EYE | Ruthenium-based photoactivated chemotherapy against eye cancer | 2020 |
| 395 | Optics-MISS | Optical Real-Time Anatomical Tracking- Minimally Invasive Spine Surgery | 2020 |
| 396 | MelImmuneOrg | Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy | 2020 |
| 397 | TESTIMONY | Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity | 2020 |
| 398 | LINKER | Elucidating transcriptional rewiring on hematological malignancies via computational methods | 2020 |
| 399 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |
| 400 | cONCReTE | DevelOpmeNt of Cancer RNA TherapEutics | 2020 |
| 401 | NetriCan | Characterization of the role of netrin-1 in the regulation of the Epithelial-to-Mesenchymal Transition during tumor progression. | 2020 |
| 402 | GlioTarget | Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer. | 2021 |
| 403 | TGF-BTB | Transforming Growth Factor – Bench To Bedside. Towards a better understanding of TGF-β isoform specific signalling in health and disease | 2020 |
| 404 | EPmIC | Controlling the susceptibility of biological cells to pulsed electric field treatment by using ion channel modulators | 2021 |
| 405 | TARNEPC | Targeting treatment-induced neuroendocrine prostate cancer | 2021 |
| 406 | BiCiCle | Biophysics of circulating tumor cells, from single molecule to cell clusters | 2020 |
| 407 | MAMBO | Magnetic swArms for liver chemoeMBOlization | 2020 |
| 408 | SPOT | SPOT - Synthesis of Pretargeted Oncology Theranostics | 2020 |
| 409 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |
| 410 | Immuno-Predictor | Mechanical Biomarkers for Prediction of Cancer Immunotherapy | 2020 |
| 411 | PRECISMEDLYM | Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine. | 2020 |
| 412 | ICG68-PROG | Imaging of c-Met aberrant cancers with Gallium-68 chelators for positron emission tomography | 2020 |
| 413 | ROSETTA | Deciphering the Role of aberrant glycOSylation in the rEsponse to Targeted TherApies for breast cancer | 2020 |
| 414 | NOSCAR | decipheriNg Oncogenic SIgnalling patterns to break CAncer drug Resistance | 2020 |
| 415 | TETCOLON | Dissecting the role of the epigenetic regulator TET2 in colorectal cancer | 2020 |
| 416 | COMMiT | Cancer Organoids Multiplexed Screening in Microfluidic Textile chips | 2020 |
| 417 | ANEUPLOIDY | Molecular origins of aneuploidies in healthy and diseased human tissues | 2020 |